About Molecular Loop
Molecular Loop is a company based in Boston (United States) founded in 2018 by Greg Porreca. Molecular Loop has raised $1.79 million across 1 funding round. The company has 12 employees as of December 31, 2022. Molecular Loop has completed 1 acquisition, including Good Start Genetics. Molecular Loop offers products and services including LoopCap Technology, Custom Panels, and SARS-CoV-2 Research Panel. Molecular Loop operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.
- Headquarter Boston, United States
- Employees 12 as on 31 Dec, 2022
- Founders Greg Porreca
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Molecular Loop Biosciences, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.79 M (USD)
in 1 rounds
-
Latest Funding Round
$1.79 M (USD), Seed
Jan 25, 2022
-
Investors
Not available
-
Employee Count
12
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Molecular Loop
Molecular Loop offers a comprehensive portfolio of products and services, including LoopCap Technology, Custom Panels, and SARS-CoV-2 Research Panel.
Enables single-tube workflow for target capture in next-generation sequencing.
Allows flexible design of custom sequencing panels for research applications.
Facilitates pathogen coverage for infectious disease genomic analysis.
Funding Insights of Molecular Loop
Molecular Loop has successfully raised a total of $1.79M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.79 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Molecular Loop
Molecular Loop has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Good Start Genetics.
Investment portfolio details for Molecular Loop
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Molecular diagnostics for inherited genetic disease screening are provided.
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for Molecular Loop
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Molecular Loop
Detailed financials for Molecular Loop
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Molecular Loop Comparisons
Peer comparison for Molecular Loop
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Molecular Loop
Molecular Loop operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
DNA sequencing platform for human genome analysis is developed.
|
|
| Locked | Locked | Locked |
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
|
| Locked | Locked | Locked |
Provider of genome analysis solutions to researchers and clinicians
|
Detailed competitors of Molecular Loop
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Molecular Loop
Complete news archive for Molecular Loop
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecular Loop
Molecular Loop was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Molecular Loop is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Greg Porreca is the current CEO of Molecular Loop. They have also founded this company.
Molecular Loop is a funded company, having raised a total of $1.79M across 1 funding round to date.
As of Dec 31, 2022, the latest employee count at Molecular Loop is 12.
Founded in 2018 and based in Boston, United States, the company operates in the biotechnology sector. Ultra-high-throughput next-generation sequencing solutions are provided for clinical applications and large-scale research projects. Workflow simplification is achieved, along with reductions in cost and time, while throughput is increased and result quality is maintained. Targeted DNA sequencing technology forms the core of these operations.
Molecular Loop offers LoopCap Technology, Custom Panels, and SARS-CoV-2 Research Panel.
Molecular Loop has made 1 acquisition, including Good Start Genetics.